Psoriasis database

To observe the efficacy and safety of systematic treatment for psoriasis

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036092

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-08-21

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

methotrexate group:methotrexate

biological agents:biological agents

Traditional Chinese Medicine:Traditional Chinese Medicine

Eligibility

Sex/Gender

All

Age

13 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients with psoriasis in the psoriasis clinic

Exclusion criteria

Exclusion criteria: Patients with psoriasis who are not consulted for specific psoriasis

Design outcomes

Primary

Measure	Time frame
the rate of PASI improvement;	—

Contacts

Public ContactKexiang Yan

Huashan Hospital, Fudan University

ykx2292002@aliyun.com+86 21 52888170

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026